Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.580
0.00 (0.00%)
Mar 20, 2026, 10:45 AM EDT - Market open
Opus Genetics Employees
Opus Genetics had 18 employees as of December 31, 2024. The number of employees increased by 4 or 28.57% compared to the previous year.
Employees
18
Change (1Y)
4
Growth (1Y)
28.57%
Revenue / Employee
$788,667
Profits / Employee
-$2,755,056
Market Cap
325.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 18 | 4 | 28.57% |
| Dec 31, 2023 | 14 | 5 | 55.56% |
| Dec 31, 2022 | 9 | 1 | 12.50% |
| Dec 31, 2021 | 8 | 3 | 60.00% |
| Dec 31, 2020 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 305 |
| Puma Biotechnology | 179 |
| AC Immune | 172 |
| Nautilus Biotechnology | 130 |
| Silence Therapeutics | 88 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 53 |
| NovaBridge Biosciences | 32 |
IRD News
- 10 days ago - Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update - GlobeNewsWire
- 17 days ago - Opus Genetics to Present at Upcoming Investor Conferences in March 2026 - GlobeNewsWire
- 20 days ago - Opus Genetics Announces Initial Clinical Data from Phase 1/2 OPGx-BEST1 Gene Therapy Study at the Macula Society Annual Meeting - GlobeNewsWire
- 23 days ago - Opus Genetics Announces FDA Acceptance of Supplemental New Drug Application for Phentolamine Ophthalmic Solution 0.75% for the Treatment of Presbyopia - GlobeNewsWire
- 25 days ago - Opus Genetics: Asymmetric Upside With LCA5 And BEST1 - Seeking Alpha
- 5 weeks ago - Opus Genetics Announces $25 Million Private Placement - GlobeNewsWire
- 6 weeks ago - Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026 - GlobeNewsWire
- 7 weeks ago - Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa - GlobeNewsWire